Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-25-049159

EVP and General Counsel sold 1,365 shares at $5.86 ($8,003)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
de Verneuil Vanina EVP and General Counsel 2025-11-03 Sale 10b5-1 −1,365 $5.86 $8,003 80,595 D
Open-market sales · 1,365 sh · avg $5.86 · $8,003
Loading xslF345X05/wk-form4_1762303236.xml…